Healthequity Stock

Healthequity EBIT

The EBIT of Healthequity (HQY) as of Aug 7, 2026 is 322.46 M USD. In the previous year, EBIT was 230.07 M USD — a change of 40.16% (higher).

EBIT

322.46 MUSD

YoY

40.16%

Last updated:

In 2026, Healthequity's EBIT was 322.46 M USD, a 40.16% increase from the 230.07 M USD EBIT recorded in the previous year.

The Healthequity EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2022
40.57 base
Jan 1, 2023
37.65 base
Jan 1, 2024
129.34 base
Jan 1, 2025
230.07 base
Jan 1, 2026
322.46 base
Jan 1, 2027 (e)
715.96 base
Jan 1, 2028 (e)
769.22 base
Jan 1, 2029 (e)
822.81 base
YEAREBIT (M USD)
2029 est 822.81
2028 est 769.22
2027 est 715.96
2026 322.46
2025 230.07
2024 129.34
2023 37.65
2022 40.57
2021 80.00
2020 62.02
2019 77.67
2018 54.42
2017 41.21
2016 26.14
2015 16.87
2014 11.52
2013 7.09
Access this data via the Eulerpool API

Healthequity Revenue

Healthequity Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
756.56 M USD
40.57 M USD
-44.29 M USD
Jan 1, 2023
861.75 M USD
37.65 M USD
-26.14 M USD
Jan 1, 2024
999.59 M USD
129.34 M USD
55.71 M USD
Jan 1, 2025
1.20 B USD
230.07 M USD
96.70 M USD
Jan 1, 2026
1.31 B USD
322.46 M USD
215.20 M USD
Jan 1, 2027 (e)
1.42 B USD
715.96 M USD
403.23 M USD
Jan 1, 2028 (e)
1.52 B USD
769.22 M USD
465.39 M USD
Jan 1, 2029 (e)
1.63 B USD
822.81 M USD
512.97 M USD

Healthequity Margins

Healthequity stock margins

The Healthequity margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Healthequity. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Healthequity.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
45.06 %
5.36 %
-5.85 %
Jan 1, 2023
45.90 %
4.37 %
-3.03 %
Jan 1, 2024
53.01 %
12.94 %
5.57 %
Jan 1, 2025
57.73 %
19.18 %
8.06 %
Jan 1, 2026
69.52 %
24.55 %
16.38 %
Jan 1, 2027 (e)
69.52 %
50.59 %
28.49 %
Jan 1, 2028 (e)
69.52 %
50.59 %
30.61 %
Jan 1, 2029 (e)
69.52 %
50.59 %
31.54 %

Healthequity Stock analysis

What does Healthequity do? Healthequity Inc. is a company specializing in health accounts and related services. The company was founded in Utah in 2002 by Stephen Neeleman and David Hall and has since become one of the leading healthcare companies in the United States. The goal of Healthequity is to help consumers maintain control over their healthcare finances and lower their healthcare expenses. To achieve this, the company offers a variety of services that allow customers to manage their healthcare finances effectively and cost-efficiently. Healthequity's business model is based on providing health accounts that allow customers to manage and maximize their healthcare budget. The accounts are linked to various health savings (HRA, HSA, FSA) that enable customers to save money for medical expenses tax-free. The company also offers a wide range of services focused on healthcare prevention, savings, and education. For example, Healthequity offers courses and training to help customers understand their healthcare finances and reduce their healthcare costs. Healthequity has also specialized in healthcare analytics. The company offers data analysis tools that allow customers to track their healthcare costs and receipts to achieve savings. In addition, Healthequity also provides unique insights into employee health and utilization behavior, providing insights into a company's health risks and enabling more tailored offerings. The company offers various products to serve its customers. One of Healthequity's key products is the health accounts themselves, which are offered in collaboration with employers or insurers. The company has also developed special offerings for small businesses, allowing them to maintain employee participation in health accounts. Other services include unique discount programs to help customers reduce their healthcare costs. Healthequity has extensive experience working with a variety of customers and is constantly developing its wide range of offerings and services. Customers who work with the company also receive outstanding customer service and support to ensure they make the most of their healthcare finances. Overall, Healthequity is a fascinating company that enables people to better manage their healthcare costs and align them with their financial goals. Healthequity's commitment to customer service, innovation, and excellent services has made it one of the leading providers of health accounts and related services. Answer: Healthequity Inc. is a company specializing in health accounts and related services, founded in Utah in 2002. Its goal is to help consumers control their healthcare finances and lower expenses through a variety of services. The company's business model revolves around health accounts that allow customers to manage and maximize their budgets. Healthequity also offers healthcare analytics and unique insights. It offers various products, including health accounts for employers or insurers, and provides excellent customer service and support. Overall, Healthequity is a leading provider of health accounts and related services. Healthequity is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Healthequity's EBIT

Healthequity's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Healthequity's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Healthequity's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Healthequity’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Healthequity stock

EBIT of Healthequity is 322.46 M USD in 2026.

EBIT of Healthequity changed from 230.07 M USD to 322.46 M USD, representing a 40.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Healthequity since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Healthequity historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Healthequity

All Key Metrics — Healthequity